Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Falling Comet
1364.4000 -18.60 (-1.34%)
NSE May 07, 2025 15:31 PM
Volume: 389.5K
 

logo
Ipca Laboratories Ltd.
30 Sep 2024
1364.40
-1.34%
buy
by Sharekhan
Target: 1734 | Target met
Sharekhan
Ipca’s board would discuss the strategic integration of Bayshore Pharmaceuticals’ generics business into Unichem Pharma (USA) Inc on September 30, 2024.
 
Ipca Laboratories Ltd. is trading below all available SMAs
More from Ipca Laboratories Ltd.
Recommended
Chart of the week: India’s changing consumer demand, policy support is driving domestic market growth
The Baseline | 07 May 2025, 05:07PM
Market closes flat, Lloyds Engineering Works' Q4 net profit declines 13.4% YoY to Rs 18.3 crore
Trendlyne Marketwatch | 07 May 2025, 03:56PM
IPCA Labs’ domestic formulations business to drive growth
| 05 Jul 2021